advanced gene platform. It's called a payment. And it's what companies do that want to buy successful technology and implement it to further their pipeline. It's called controlled dilution and it's WAY better than other types of financing.
In fact, the Intrexon deal is really what sparked the PPS increase. Particularly as Intrexon has a record of success and as part of the deal, they get to buy more on the open market. Their involvement is a validation for AEN.
"Par Value". Look at any 10-K from Apple, Google, Amazon, Intel, etc. and you'll see the same verbiage.
Then go think about the fact that you don't know anything about the complex world of stock investing and you should probably go invest in stamps or coins or comic books or something your pea brain can comprehend.